Much nonsense has been written in the past two years about equity valuations. We read that we should...
Much nonsense has been written in the past two years about equity valuations. We read that we should ignore old fashioned, tried and tested measures of valuation. Instead, new measures were invented that had a lower multiple attached to them and made expensive shares look cheap. Rather than look at earnings, assets and cash, many analysts were concentrating on sales multiples and, through the skillful use of complex discounted cashflow models, were able to create price targets that resulted in predictably laughable results. I remember a top-rated analyst set a £40 price target on a FT...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes